JBIO- Jade Biosciences, Inc.

Name: Jade Biosciences, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

JBIO sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Compare Health Care sector insider flows →

Insider Ownership

Role	Insider	Shares	Value	30d
Other	King Andrew James	386.1K	-	-
CEO	Frohlich Tom	86.3K	-	-
Dir	Eisner Mark	47.7K	-	-
CFO	Dahms Bradford D.	37.8K	-	-
Dir	Cain Christopher W.	34.8K	-	-

Activity

Buys and sells only

Transactions

10 filings · page 6

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 5, 2023	Niven Ralph74	Chief Scientific Officer	Sale+OE	2,250	$16.26	$36,576.00	-58.3%	-4.6%	+2.6%
May 19, 2023	Gillies Hunter82	Chief Medical Officer	Sale+OE	65	$19.50	$1,267.50	-2.0%	-19.7%	+10.9%
May 17, 2023	Gillies Hunter82	Chief Medical Officer	Sale+OE	1,090	$19.59	$21,355.83	-25.1%	-24.0%	+12.6%
May 8, 2023	Dake Benjamin T77	See Remarks	Sale+OE	10,284	$21.80	$224,159.85	-88.8%	-30.4%	-6.9%
May 5, 2023	Niven Ralph74	Chief Scientific Officer	Sale+OE	2,250	$20.87	$46,956.82	-58.3%	-25.1%	-7.8%
May 3, 2023	Verwijs Marinus82	Senior Vice President, Cmc	Sell	759	$20.79	$15,779.38	-100%	-22.9%	-4.6%
May 2, 2023	Noyes Timothy P81	Chief Executive Officer	Sale+OE	15,693	$20.63	$323,745.45	-100%	-15.9%	+0.4%
Apr 21, 2023	Gillies Hunter82	Chief Medical Officer	Sale+OE	4,000	$19.50	$78,000.00	-67.1%	-16.6%	+13.0%
Apr 6, 2023	Dake Benjamin T77	See Remarks	Sale+OE	10,283	$18.17	$186,828.74	-100%	-6.9%	+37.0%
Apr 5, 2023	Niven Ralph74	Chief Scientific Officer	Sale+OE	2,250	$18.20	$40,942.29	-58.3%	-8.2%	+56.9%

Understand these filings

How to Read SEC Form 4 Filings →Understanding Insider Buying Signals →What is Insider Trading? A Complete Guide →Cluster Buying: When Multiple Insiders Buy Together →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC